SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-028523
Filing Date
2024-03-08
Accepted
2024-03-08 13:53:26
Documents
104
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K eypt-20231231.htm   iXBRL 10-K 3098244
2 EX-4.3 eypt-ex4_3.htm EX-4.3 28050
3 EX-10.17 eypt-ex10_17.htm EX-10.17 147006
4 EX-10.20 eypt-ex10_20.htm EX-10.20 46565
5 EX-10.21 eypt-ex10_21.htm EX-10.21 64739
6 EX-21.1 eypt-ex21_1.htm EX-21.1 6721
7 EX-23.1 eypt-ex23_1.htm EX-23.1 2451
8 EX-31.1 eypt-ex31_1.htm EX-31.1 12719
9 EX-31.2 eypt-ex31_2.htm EX-31.2 12789
10 EX-32.1 eypt-ex32_1.htm EX-32.1 5829
11 EX-32.2 eypt-ex32_2.htm EX-32.2 5916
12 EX-97.1 eypt-ex97_1.htm EX-97.1 69765
  Complete submission text file 0000950170-24-028523.txt   12362483

Data Files

Seq Description Document Type Size
13 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT eypt-20231231.xsd EX-101.SCH 1810192
106 EXTRACTED XBRL INSTANCE DOCUMENT eypt-20231231_htm.xml XML 1929796
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Filer) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-51122 | Film No.: 24733597
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)